• FirefoxTry Yahoo Finance on Firefox »
  •  Dow Down 0.52% Nasdaq Down 0.25%

    Alexion Pharmaceuticals, Inc. (ALXN)

    -NasdaqGS
    195.73 Down 1.71(0.87%) Aug 3, 4:00PM EDT
    Add to Portfolio
    Prev Close:197.44
    Open:196.88
    Bid:190.16 x 1600
    Ask:N/A
    1y Target Est:225.61
    Beta:1.18
    Earnings Date:Oct 21 - Oct 26 (Est.)
    Day's Range:193.52 - 199.00
    52wk Range:150.06 - 208.88
    Volume:1,364,859
    Avg Vol (3m):2,253,050
    Market Cap:43.87B
    P/E (ttm):67.05
    EPS (ttm):2.92
    Div & Yield:N/A (N/A)
    Quotes delayed, except where indicated otherwise. Currency in USD.

    Comparison

    Symbol% ChgMkt Cap
    ALXNDown 0.87%43.87B
    AMGNDown 0.57%133.51B
    BAXDown 1.42%21.47B

    Key Statistics

    Forward P/E (1 yr):32.79
    P/S (ttm):17.38
    Ex-Dividend Date:N/A

    Analysts

    Annual EPS Est (Dec-15) :4.84
    Quarterly EPS Est (Sep-15) :1.03
    Mean Recommendation*:1.8
    PEG Ratio (5 yr expected):2.40

    * (Strong Buy) 1.0 - 5.0 (Sell)

    Analyst Opinion | Estimates

    Business Summary

    Alexion Pharmaceuticals, Inc., a biopharmaceutical company, develops and commercializes life-transforming therapeutic products. It offers Soliris (eculizumab), a therapeutic product to treat paroxysmal nocturnal hemoglobinuria (PNH), a genetic blo... View More
    Your browser doesn't support canvas
    SETTINGS
    Scrolling
    Speed
    Display
    Price
    Submit Feedback